Krishna Institute of Medical Sciences Ltd

Krishna Institu. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Krishna Institute of Medical Sciences Ltd

₹ 806 0.04%
08 Jul - close price
kimshospitals.com BSE: 543308 NSE: KIMS
About

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

Key Points

Regional Leadership
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields. [1]

Website BSE NSE
  • Market Cap ₹ 33,850 Cr.
  • Current Price ₹ 806
  • High / Low ₹ 858 / 576
  • Stock P/E 136
  • Book Value ₹ 56.2
  • Dividend Yield 0.00 %
  • ROCE 9.29 %
  • ROE 11.3 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company's median sales growth is 21.9% of last 10 years

Cons

  • Stock is trading at 14.4 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -4.73%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Select Index BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
576 606 652 606 634 688 777 772 797 872 961 998 1,075
413 449 475 459 475 509 559 585 599 679 757 799 868
Operating Profit 163 157 177 147 159 179 218 187 198 193 204 199 206
OPM % 28% 26% 27% 24% 25% 26% 28% 24% 25% 22% 21% 20% 19%
5 3 3 3 4 5 5 18 15 7 4 5 1
Interest 5 9 9 12 16 18 20 26 27 33 45 57 68
Depreciation 35 32 33 35 46 39 41 45 53 53 66 79 85
Profit before tax 127 119 139 102 100 127 162 135 134 114 97 69 55
Tax % 22% 27% 27% 25% 28% 25% 26% 31% 21% 25% 26% 24% 40%
99 87 101 77 72 95 121 92 106 85 72 52 33
EPS in Rs 2.33 2.02 2.30 1.80 1.64 2.16 2.68 2.22 2.54 1.96 1.67 1.33 1.06
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
512 567 664 918 1,123 1,330 1,651 2,198 2,498 3,035 3,905
403 450 593 833 872 953 1,126 1,587 1,850 2,242 3,103
Operating Profit 109 118 71 85 251 377 524 611 648 793 802
OPM % 21% 21% 11% 9% 22% 28% 32% 28% 26% 26% 21%
5 3 37 6 5 9 27 41 13 43 18
Interest 37 32 88 49 44 37 22 37 55 100 202
Depreciation 36 35 40 56 71 70 73 129 147 177 283
Profit before tax 41 53 -20 -15 141 279 457 485 460 558 334
Tax % 32% 37% 126% 223% 18% 26% 25% 25% 27% 26% 28%
28 33 -46 -49 115 205 344 366 336 415 242
EPS in Rs 0.76 0.91 -1.32 -1.28 3.20 5.19 8.32 8.41 7.75 9.61 6.03
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 23%
5 Years: 24%
3 Years: 21%
TTM: 29%
Compounded Profit Growth
10 Years: 25%
5 Years: 4%
3 Years: -9%
TTM: -32%
Stock Price CAGR
10 Years: %
5 Years: 29%
3 Years: 31%
1 Year: 14%
Return on Equity
10 Years: 18%
5 Years: 18%
3 Years: 16%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 70 72 50 74 74 78 80 80 80 80 80
Reserves 193 255 -209 466 524 786 1,307 1,590 1,748 2,058 2,167
256 280 753 336 369 316 257 678 1,355 2,557 4,253
146 167 359 237 228 253 260 553 636 995 1,258
Total Liabilities 665 774 954 1,114 1,194 1,433 1,904 2,901 3,820 5,689 7,759
515 518 755 863 916 931 1,005 1,766 2,434 3,348 5,710
CWIP 2 64 0 0 2 9 21 477 600 1,214 606
Investments 11 14 0 0 0 0 332 68 157 99 103
137 177 199 250 276 493 546 590 629 1,028 1,339
Total Assets 665 774 954 1,114 1,194 1,433 1,904 2,901 3,820 5,689 7,759

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
95 82 106 134 202 356 324 432 521 582 511
-41 -100 -64 -110 -125 -354 -412 -416 -753 -1,116 -1,452
-65 24 -39 -27 -44 10 61 20 217 543 940
Net Cash Flow -11 5 3 -3 32 12 -26 36 -15 9 -1
Free Cash Flow 61 -18 49 57 150 262 154 -140 -125 -380 -902
CFO/OP 88% 80% 192% 195% 102% 104% 86% 87% 102% 91% 83%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 47 59 59 49 43 30 28 42 43 48 52
Inventory Days 36 43 46 47 44 30 37 44
Days Payable 194 207 215 181 177 167 133 146
Cash Conversion Cycle -111 -105 -110 -85 -91 -106 -67 42 43 48 -50
Working Capital Days 11 26 -333 -15 -15 -31 -3 8 -5 -29 -35
ROCE % 15% 11% 5% 20% 29% 34% 24% 17% 15% 9%

Insights

In beta
Mar 2015 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ARPOB (Average Revenue Per Occupied Bed)
Rs

Log in to view insights

Please log in to see hidden values.

Login
Bed Occupancy
%
Total Bed Capacity
Beds
ALOS (Average Length of Stay)
Days
IP Volume (Inpatient Volume)
Patients
OP Volume (Outpatient Volume)
Patients
Operational Beds
Beds
ARPP (Average Revenue Per Patient)
Rs
Specialty Mix - Cardiac Sciences
% of revenue

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
38.85% 38.85% 38.82% 38.82% 38.82% 38.82% 38.82% 38.82% 34.11% 34.11% 34.11% 34.11%
13.15% 14.24% 15.27% 16.73% 17.84% 15.85% 15.68% 15.44% 15.54% 15.03% 14.33% 14.57%
35.77% 34.80% 34.24% 33.13% 32.12% 32.29% 32.05% 31.95% 31.65% 32.12% 32.72% 32.50%
12.23% 12.10% 11.67% 11.32% 11.22% 13.03% 13.45% 13.78% 18.68% 18.74% 18.85% 18.82%
No. of Shareholders 65,44966,95771,01469,09269,06377,61795,4681,01,8951,08,9551,04,8721,01,59993,333

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls